Stella Apostolaki

3.0k total citations
43 papers, 2.4k citations indexed

About

Stella Apostolaki is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stella Apostolaki has authored 43 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 21 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stella Apostolaki's work include Cancer Cells and Metastasis (32 papers), Cancer Genomics and Diagnostics (13 papers) and Metastasis and carcinoma case studies (12 papers). Stella Apostolaki is often cited by papers focused on Cancer Cells and Metastasis (32 papers), Cancer Genomics and Diagnostics (13 papers) and Metastasis and carcinoma case studies (12 papers). Stella Apostolaki collaborates with scholars based in Greece, Belgium and Sweden. Stella Apostolaki's co-authors include Maria Perraki, Vassilis Georgoulias, Evi Lianidou, Dimitris Mavroudis, Aliki Stathopoulou, N. Xenidis, D. Mavroudis, Efstathios N. Stathopoulos, Sofia Agelaki and Maria Kafousi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Stella Apostolaki

43 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stella Apostolaki Greece	24	2.0k	1.5k	689	478	226	43	2.4k
Maria Perraki Greece	24	2.0k 1.0×	1.5k 1.0×	682 1.0×	492 1.0×	229 1.0×	49	2.4k
Robert Szczepaniak‐Sloane United Kingdom	10	1.9k 0.9×	1.2k 0.8×	755 1.1×	422 0.9×	452 2.0×	12	2.3k
Bruce Saidman United States	11	1.8k 0.9×	1.2k 0.8×	508 0.7×	354 0.7×	440 1.9×	14	2.2k
Martina Komor Germany	15	1.6k 0.8×	744 0.5×	352 0.5×	586 1.2×	109 0.5×	25	2.5k
Aliki Stathopoulou Greece	12	1.1k 0.5×	838 0.6×	351 0.5×	335 0.7×	141 0.6×	18	1.3k
Marilyn Leitch United States	10	1.0k 0.5×	969 0.6×	309 0.4×	287 0.6×	159 0.7×	18	1.5k
Maria Kafousi Greece	18	946 0.5×	808 0.5×	345 0.5×	504 1.1×	110 0.5×	42	1.6k
Iris Schrader Germany	12	1.8k 0.9×	874 0.6×	398 0.6×	335 0.7×	115 0.5×	27	2.2k
Eleni Politaki Greece	16	1.0k 0.5×	810 0.5×	335 0.5×	396 0.8×	148 0.7×	29	1.3k
F. Hepp Germany	10	1.3k 0.6×	830 0.5×	356 0.5×	358 0.7×	71 0.3×	14	1.7k

Countries citing papers authored by Stella Apostolaki

Since Specialization

Citations

This map shows the geographic impact of Stella Apostolaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella Apostolaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella Apostolaki more than expected).

Fields of papers citing papers by Stella Apostolaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stella Apostolaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella Apostolaki. The network helps show where Stella Apostolaki may publish in the future.

Co-authorship network of co-authors of Stella Apostolaki

This figure shows the co-authorship network connecting the top 25 collaborators of Stella Apostolaki. A scholar is included among the top collaborators of Stella Apostolaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella Apostolaki. Stella Apostolaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spiliotaki, Maria, Galatea Kallergi, Christos Nikolaou, et al.. (2021). Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(−) breast cancer receiving salvage treatment with everolimus/exemestane. Cancer Chemotherapy and Pharmacology. 87(2). 277–287. 4 indexed citations

Messaritakis, Ippokratis, Eleni Politaki, Stella Apostolaki, et al.. (2018). Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib. Scientific Reports. 8(1). 2238–2238. 14 indexed citations

Messaritakis, Ippokratis, Eleni Politaki, Stella Apostolaki, et al.. (2015). Detection of circulating tumor cells in the peripheral blood of patients with small cell lung cancer (SCLC) using both the CellSearch platform and immunofluorescence: Correlation with clinicopathological features.. Journal of Clinical Oncology. 33(15_suppl). 7573–7573. 1 indexed citations

Xenidis, N., Maria Perraki, Stella Apostolaki, et al.. (2013). Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer. British Journal of Cancer. 108(3). 549–556. 25 indexed citations

Daskalakis, Markos, Dimitriοs Mavroudis, Elias Sanidas, et al.. (2011). Assessment of the effect of surgery on the kinetics of circulating tumour cells in patients with operable breast cancer based on cytokeratin-19 mRNA detection. European Journal of Surgical Oncology. 37(5). 404–410. 14 indexed citations

Vardakis, N., Ippokratis Messaritakis, Chara Papadaki, et al.. (2010). Prognostic Significance of the Detection of Peripheral Blood CEACAM5mRNA-Positive Cells by Real-Time Polymerase Chain Reaction in Operable Colorectal Cancer. Clinical Cancer Research. 17(1). 165–173. 22 indexed citations

Agelaki, Sofia, Maria Perraki, Stella Apostolaki, et al.. (2010). Trastuzumab versus observation in women with early breast cancer and CK-19 mRNA-positive circulating tumor cells (CTCs): A pilot randomized phase II study.. Journal of Clinical Oncology. 28(15_suppl). 547–547. 3 indexed citations

Perraki, Maria, Sofia Agelaki, Stella Apostolaki, et al.. (2009). 1092 Detection of cytokeratin-19 mRNA-positive cells in peripheral blood and bone marrow of patients with operable breast cancer. European Journal of Cancer Supplements. 7(2). 112–112. 2 indexed citations

Agelaki, Sofia, Maria Perraki, Stella Apostolaki, et al.. (2009). Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer. British Journal of Cancer. 101(4). 589–597. 79 indexed citations

10.

Ignatiadis, Michail, Galatea Kallergi, Maria Ntoulia, et al.. (2008). Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer. Clinical Cancer Research. 14(9). 2593–2600. 181 indexed citations

11.

Apostolaki, Stella, Maria Perraki, Galatea Kallergi, et al.. (2008). Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance. Breast Cancer Research and Treatment. 117(3). 525–534. 42 indexed citations

12.

Apostolaki, Stella, Maria Perraki, Athanasios Pallis, et al.. (2007). Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance. Annals of Oncology. 18(5). 851–858. 63 indexed citations

13.

Xenidis, N., Stella Apostolaki, Maria Perraki, et al.. (2007). Clinical relevance of circulating CK-19 mRNA-positive cells detected during the period of adjuvant tamoxifen treatment in patients with early breast cancer. Journal of Clinical Oncology. 25(18_suppl). 10534–10534. 1 indexed citations

14.

Xenidis, N., Stella Apostolaki, Maria Perraki, et al.. (2007). Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer. Annals of Oncology. 18(10). 1623–1631. 56 indexed citations

15.

Apostolaki, Stella, Maria Perraki, Eleni Politaki, et al.. (2006). Detection of HER2 and CK-19 mRNA-positive circulating tumor cells (CTCs) in the peripheral blood of patients with early stage breast cancer.. Cancer Research. 66. 1207–1207. 3 indexed citations

16.

Stathopoulou, Aliki, Maria Ntoulia, Maria Perraki, et al.. (2006). A highly specific real‐time RT‐PCR method for the quantitative determination of CK‐19 mRNA positive cells in peripheral blood of patients with operable breast cancer. International Journal of Cancer. 119(7). 1654–1659. 75 indexed citations

17.

Xenidis, N., Charalambos Kouroussis, Athanasios Pallis, et al.. (2005). Effect of adjuvant tamoxifen and letrozol on the fate of peripheral blood CK-19 mRNA+ cells in patients with early breast cancer. Journal of Clinical Oncology. 23(16_suppl). 754–754. 3 indexed citations

18.

Mavroudis, Dimitris, Maria Perraki, Savvas Papadopoulos, et al.. (2004). Trastuzumab Administration Can Effectively Target Chemotherapy-Resistant Cytokeratin-19 Messenger RNA–Positive Tumor Cells in the Peripheral Blood and Bone Marrow of Patients With Breast Cancer. Clinical Cancer Research. 10(24). 8185–8194. 109 indexed citations

19.

Xenidis, Nikolaos, Ioannis G. Vlachonikolis, D. Mavroudis, et al.. (2003). Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer. Annals of Oncology. 14(6). 849–855. 88 indexed citations

20.

Kotsakis, Αthanasios, Michael I. Koukourakis, Stella Apostolaki, et al.. (2000). Docetaxel-induced lymphopenia in patients with solid tumors. Cancer. 89(6). 1380–1386. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact